Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Revenue
€ 538,596
▼ 87% vs 2023
Profit
Caution€ -30,977
▲ 98% vs 2023
Debts
Low€ 101,098
▼ 94% vs 2023
OMEGA PHARMA TRADING from Gent, company number BE0417092080, closed financial year 2025 with a result of € -30,977 after tax. For that financial year OMEGA PHARMA TRADING recorded revenue of € 538,596 and equity of € 2.7 million. Compared with financial year 2023, the result moved from € -1.5 million to € -30,977. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at OMEGA PHARMA TRADING?
What happened at OMEGA PHARMA TRADING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jonas Dhaenens stepped down as director. NBB
- Sonia Hollies stepped down as director. NBB
- Magali Verbraeken stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 30,977. Source: NBB ↗
- Anja van Winsberghe stepped down as director. NBB
- Jonas Dhaenens became a director. NBB
- Sonia Hollies became a director. NBB
- New establishment in Gent. KBO
In short
From € 2.3 million profit in 2021 to € 30,977 loss in 2025.
Paid € 1.2 million in corporate taxes since 2021.
Best year ever: 2021, with € 2.3 million profit.
Pays suppliers within 62 days on average.
A new publication or filing at OMEGA PHARMA TRADING? We notify you, reason included.
Follow OMEGA PHARMA TRADINGNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Perrigo Belgium NV (100%).
Directors
According to the 2025 annual accounts
Magali Verbraeken
Director
Also active at: MEDGENIX BENELUX, Perrigo Belgium, Perrigo Capital +5 more
since 2023 · until 2029
Anja van Winsberghe
Director
Also active at: MEDGENIX BENELUX, Perrigo Belgium, Perrigo Capital +7 more
since 2023 · until 2026
Sonia Hollies
Managing director
since 2024 · until 2030
Jonas Dhaenens
Director
Also active at: Perrigo Capital, Perrigo Holding, Perrigo Europe Invest +3 more
since 2026 · until 2032
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Gaston Crommenlaan 6 box 606
9050 Gent
Venecoweg 26
9810 Nazareth-De Pinte
Active since 15 May 1977
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
Perrigo Belgium same network
€ 44.6 million revenue · 2025
Perrigo Capital same network
€ 2.2 million revenue · 2025
Perrigo Holding same network
€ 48.4 million revenue · 2025
Perrigo Europe Invest same network
Oce-Bio same network
€ 4.1 million revenue · 2025
+9 more
Details
- Company number
- 0417.092.080
- VAT number
- BE 0417.092.080
- Registered office
- Gaston Crommenlaan 6 bus 606, 9050 Gent
- Names & denominations
- OMEGA PHARMA TRADING
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 April 1977
- Peppol
- Active · Active since 8 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in andere consumentenartikelen, neg